Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.
Looking for a particular Third Pole Therapeutics employee's phone or email?
The Third Pole Therapeutics annual revenue was $10.1 million in 2026.
Bill Athenson is the CEO of Third Pole Therapeutics.
36 people are employed at Third Pole Therapeutics.
Third Pole Therapeutics is based in Waltham, Massachusetts.
The NAICS codes for Third Pole Therapeutics are [54171, 54, 541, 5417, 541714].
The SIC codes for Third Pole Therapeutics are [87, 873].